A new 1: 1 drug–drug cocrystal of temozolomide and hesperetin was successfully prepared
by liquid-assisted grinding, slurry conversion crystallization, and evaporation crystallization …

To improve the solubility and dissolution rate of the BCS class II drug ketoconazole, five
novel solid forms in 1: 1 stoichiometry were obtained upon liquid-assisted grinding, slurry …

We report novel pharmaceutical cocrystal of a popular antipyretic drug paracetamol (PCA)
with coformer 5-nitroisophhthalic acid (5NIP) to improve its tabletability. The cocrystal (PCA …

Pharmaceutical salt formation is the most preferred and effective method to enhance the
physicochemical properties of an active pharmaceutical ingredient (API) such as solubility …

Dapagliflozin (DAP) is a potent and selective sodium-glucose contransporter-2 inhibitor, for
treating type 2 diabetes. DAP propanediol monohydrate (DAP-PDO-H 2 O, 1: 1: 1) is the …

Allopurinol is a xanthine oxidase inhibitor with poor solubility and permeability, which
severely limit its drug absorption following the administration of some dosage forms, such as …

The 1: 1 cocrystal of the antifungal agent ketoconazole with p-aminobenzoic acid was
successfully crystallized and systematically characterized by a physical and …

Nano-anticancer drugs are gaining importance in cancer treatment due to their unique
properties and wide range of applications. The efforts are made to synthesize silver …

The aim of this work was to improve the dissolution rate of a poorly water–soluble antifungal
drug, ketoconazole (KET), by forming cocrystal with 4-amino benzoic acid (PABA). Gas Anti …

We report novel pharmaceutical salts of an anti-hypertensive drug carvedilol (CVD) with
pharmaceutically acceptable salt formers, including oxalic acid (OXA), fumaric acid (FUMA) …